Research output

1. EARLY GOOD LATER BETTER. RELATIONSHIP OF BCR-ABL LEVEL AT 12 MONTHS OF TARGET THERAPY WITH INDIVIDUAL CHARACTERISTICS OF MOLECULAR RESPONSE IN EARLY TREATMENT PERIOD IN CHRONIC MYELOID LEUKEMIA

   Research output: Contribution to journal › Meeting Abstract › peer-review

2. RESULTS OF OBSERVATION WITHOUT TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE WHO STOPPED THERAPY DUE TO PREGNANCY, ADVERSE EVENTS OR BY OWN CONSIDERATION

   Research output: Contribution to journal › Meeting Abstract › peer-review

3. THE RATE OF BCR-ABL DECLINE AS AN OPTIMIZED PREDICTOR OF OUTCOME FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE ON TREATMENT WITH TYROSINE KINASE INHIBITORS

   Research output: Contribution to journal › Meeting Abstract › peer-review

View all (3) »